MedPath

Effect of blood sugar circadian variation using the CGM of SGLT2 inhibitors in patients with type 2 diabetes

Not Applicable
Conditions
Type2 Diabetes
Registration Number
JPRN-UMIN000019429
Lead Sponsor
Dokkyo Medical University Department of Endocrinology and Metabolism
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

Type 1 diabetes

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
blood sugar circadian variation
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath